Widely prescribed, newer-generation antipsychotic drugs are no more effective for the treatment of schizophrenia in children and teens than older, cheaper drugs, a government-funded study shows.
Under the direction of the National Institute of Mental Health (NIMH), researchers compared two of the newer drugs, known as atypical antipsychotics, to an older-generation antipsychotic. They found no major differences in treatment outcomes, but big differences in side effects among young patients taking the newer and older drugs.
Newer Antipsychotics No Better in Kids
For addicts, cravings override all normal rules of behavior. In interviews throughout Northern Kentucky, addicts and...
A new initiative announced by the President Barack Obama Friday will see renewed efforts to collect...
The CDC warned the 2014-15 flu season would be a bad one and new numbers from...
The American Academy of Pediatrics (AAP), which has the largest pediatric publishing program in the world,...
